Strategic Diagnostics' Q3 Profit Erased on Increased Tax Expense | GenomeWeb
NEW YORK (GenomeWeb News) — Strategic Diagnostics said Wednesday that a $100,000 tax adjustment has erased its entire third-quarter profit.
 
The company’s original earnings report for the three months ended Sept. 30, disclosed Nov. 1, showed a $100,000 profit, which was a decline from the $332,000 it earned during the comparable period one year earlier.
  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.